Literature DB >> 11423512

Amniotic fluid insulin at 14-20 weeks' gestation: association with later maternal glucose intolerance and birth macrosomia.

M W Carpenter1, J A Canick, J W Hogan, C Shellum, M Somers, J A Star.   

Abstract

OBJECTIVE: To examine the hypothesis that early second trimester amniotic fluid (AF) insulin concentration is elevated and later fetal growth is augmented in gravidas demonstrating later oral glucose intolerance. RESEARCH DESIGN AND METHODS: In this prospective observational cohort study, AF was sampled at 14-20 weeks' gestation in 247 subjects, and 1-h 50-g oral glucose challenge tests (GCTs) were performed at > or = 24 weeks. AF insulin was assayed by an automated immuno-chemiluminometric assay (8). Macrosomia was defined as birth weight above the 90th centile.
RESULTS: AF insulin concentration (range 1.4-44.5 pmol/l) correlated positively with gestational age and maternal weight. A logistic regression analysis, adjusted for maternal age and midpregnancy weight, showed increased AF insulin multiples of gestational age-specific medians to be associated with subsequently diagnosed gestational diabetes mellitus (GDM) (OR 1.9, CI 1.3-2.4, P = 0.029). Among 60 subjects with GCT values > 7.2 mmol/l, each unit increase in AF insulin multiple of median (MOM) was associated with a threefold increase in fetal macrosomia incidence (3.1, 1.3-4.9, P = 0.048).
CONCLUSIONS: An elevated AF insulin concentration at 14-20 weeks' gestation is associated with subsequently documented maternal glucose intolerance. Among gravidas with GCT values > 7.2 mmol/l, elevated early AF insulin concentration is associated with fetal macrosomia. Maternal glucose intolerance may affect fetal insulin production before 20 weeks' gestation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11423512     DOI: 10.2337/diacare.24.7.1259

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  13 in total

1.  Concealed maternal blood glucose excursions correlate with birth weight centile.

Authors:  Masoud Mark Taslimi; Kasra Navabi; Reinaldo Acosta; Amy Helmer; Yasser Y El-Sayed
Journal:  J Diabetes Sci Technol       Date:  2008-05

2.  Circulating early- and mid-pregnancy microRNAs and risk of gestational diabetes.

Authors:  Pandora L Wander; Edward J Boyko; Karin Hevner; Viraj J Parikh; Mahlet G Tadesse; Tanya K Sorensen; Michelle A Williams; Daniel A Enquobahrie
Journal:  Diabetes Res Clin Pract       Date:  2017-07-25       Impact factor: 5.602

3.  Ancestry-Matched and Cross-Ancestry Genetic Risk Scores of Type 2 Diabetes in Pregnant Women and Fetal Growth: A Study in an Ancestrally Diverse Cohort.

Authors:  Marion Ouidir; Xuehuo Zeng; Suvo Chatterjee; Cuilin Zhang; Fasil Tekola-Ayele
Journal:  Diabetes       Date:  2022-02-01       Impact factor: 9.461

4.  Sex differences in the association of cord blood insulin with subcutaneous adipose tissue in neonates.

Authors:  M Eder; B Csapo; C Wadsack; J Haas; P M Catalano; G Desoye; M N M van Poppel
Journal:  Int J Obes (Lond)       Date:  2015-09-21       Impact factor: 5.095

Review 5.  Maternal-fetal transport of hypoglycaemic drugs.

Authors:  Facundo Garcia-Bournissen; Denice S Feig; Gideon Koren
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 6.  Current controversies in the mechanisms and treatment of gestational diabetes.

Authors:  Gyula Tamás; Zsuzsa Kerényi
Journal:  Curr Diab Rep       Date:  2002-08       Impact factor: 4.810

7.  Research Gaps in Gestational Diabetes Mellitus: Executive Summary of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop.

Authors:  Deborah J Wexler; Camille E Powe; Linda A Barbour; Thomas Buchanan; Donald R Coustan; Rosa Corcoy; Peter Damm; Fidelma Dunne; Denice S Feig; Assiamira Ferrara; Lorie M Harper; Mark B Landon; Sara J Meltzer; Boyd E Metzger; Hilary Roeder; Janet A Rowan; David A Sacks; David Simmons; Jason G Umans; Patrick M Catalano
Journal:  Obstet Gynecol       Date:  2018-08       Impact factor: 7.661

8.  Opportunities for Prevention of Gestational Diabetes Before 24 Weeks of Gestation.

Authors:  Decui Cheng; Feifei Li; Xuexin Zhou; Xianming Xu
Journal:  Diabetes Metab Syndr Obes       Date:  2021-02-24       Impact factor: 3.168

9.  Fetal exposure to altered amniotic fluid glucose, insulin, and insulin-like growth factor-binding protein 1 occurs before screening for gestational diabetes mellitus.

Authors:  Daniel K Tisi; David H Burns; Gary W Luskey; Kristine G Koski
Journal:  Diabetes Care       Date:  2010-09-20       Impact factor: 19.112

10.  Gestational diabetes mellitus: Get, set, go From diabetes capital of the world to diabetes care capital of the world.

Authors:  Navneet Magon
Journal:  Indian J Endocrinol Metab       Date:  2011-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.